Zobrazeno 71 - 80
of 189
pro vyhledávání: '"59"'
Publikováno v:
Caspian Journal of Neurological Sciences. 1:33-40
Article type: Original Article Background: Epilepsy is the second common neurologic disorder. Although many antiepileptic drugs have been formulated to control the seizures, but not all seizures have been controlled by them. Uncontrolled epilepsy can
Publikováno v:
Archives of Gerontology and Geriatrics. 61:212-216
Objectives Comparison of effectiveness and safety of solifenacin and mirabegron, as well as their combination, for managing heavy symptoms of overactive bladder. Materials and methods All patients who participated in the examination (average age: 71.
Autor:
Radoslav Chekerov, Jalid Sehouli, Rolf Richter, Hannah Woopen, Jacek P. Grabowski, Hannah Rittmeister
Publikováno v:
Anticancer research. 38(10)
BACKGROUND/AIM Chemotherapy-associated toxicity is one of the limiting factors regarding treatment efficacy, patient outcome and quality of life in this collective. Underweight or obese patients represent a major group in which the therapy seems to b
Autor:
Khaled Abdelgawwad, Miriam Bach, Jan Beyer-Westendorf, Yoriko De Sanctis, Anthony Maraveyas, Agnes Yuet Ying Lee, Samuel Fatoba, Alexander T. Cohen, Lorenzo G. Mantovani
Publikováno v:
Blood. 134:2161-2161
Background: Patients living with cancer who develop venous thromboembolism (VTE) have a high risk of VTE recurrence, and traditional anticoagulants (low molecular weight heparin [LMWH] or vitamin K antagonists [VKAs]) are associated with significant
Autor:
John G. Matthews, Tracy Staton, Cecile T.J. Holweg, David F. Choy, Rebecca N. Bauer, Julie Olsson, Xiaoying Yang, Joseph R. Arron
Publikováno v:
BMJ Open Respiratory Research
IntroductionAsthma exacerbations spike in the spring and autumn months, yet the seasonal variation of asthma symptoms and lung function is poorly studied.MethodsSeasonal variation of lung function, rescue medication use and patient-reported symptoms
Autor:
Louis Marie Dourthe, Guillaume Ploussard, M Lukac, Suzy Van Sanden, Dominique Beal-Ardisson, Geneviève Pissart, Redas Trepiakas, Laurent Antoni, Elias Pintus, Alison Reid, Antoine Thiery-Vuillemin, Mads Hvid Poulsen, Edouard Lagneau, A. Birtle
Publikováno v:
ESMO Open
Thiery-Vuillemin, A, Hvid Poulsen, M, Lagneau, E, Ploussard, G, Birtle, A, Dourthe, L M, Beal-Ardisson, D, Pintus, E, Trepiakas, R, Antoni, L, Lukac, M, Van Sanden, S, Pissart, G & Reid, A 2018, ' Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer : Initial results from the observational AQUARiUS study ', ESMO Open, vol. 3, no. 5, e000397 . https://doi.org/10.1136/esmoopen-2018-000397
Thiery-Vuillemin, A, Hvid Poulsen, M, Lagneau, E, Ploussard, G, Birtle, A, Dourthe, L M, Beal-Ardisson, D, Pintus, E, Trepiakas, R, Antoni, L, Lukac, M, Van Sanden, S, Pissart, G & Reid, A 2018, ' Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer : Initial results from the observational AQUARiUS study ', ESMO Open, vol. 3, no. 5, e000397 . https://doi.org/10.1136/esmoopen-2018-000397
Introduction Abiraterone acetate plus prednisone (AAP) and enzalutamide (ENZ) are commonly prescribed for metastatic castration-resistant prostate cancer (mCRPC). Data comparing their effects on patient-reported outcomes (PROs) from routine clinical
Autor:
Gerrit D. Slooter, Jan H. Wijsman, Felice N. van Erning, Art Vreugenhil, Maryska L.G. Janssen-Heijnen, Valery E.P.P. Lemmens, Lonneke V. van de Poll-Franse, Tonneke Beijers, Johannes A. Wegdam
Publikováno v:
Clinical Colorectal Cancer, 16(3), 195-203. CIG Media Group, L.P.
Clinical Colorectal Cancer, 16(3), 195-203. Elsevier
Clinical Colorectal Cancer, 16(3), 195-203. Elsevier
The course of neuropathic symptoms among elderly patients with stage III colon cancer treated with CAPOX (capecitabine, oxaliplatin), capecitabine, or no chemotherapy was investigated. A total of 117 patients (76%) selected from the Netherlands Cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08921628484ec368e14f25ef6cb77ddd
https://cris.maastrichtuniversity.nl/en/publications/7d13e086-1fb6-40ff-bc58-5a8304573849
https://cris.maastrichtuniversity.nl/en/publications/7d13e086-1fb6-40ff-bc58-5a8304573849
Autor:
A.R. Authen, D. Solbu, Finn Gustafsson, Einar Gude, Hans Eiskjær, Arne K. Andreassen, Kristjan Karason, Satish Arora, I. Grov, Göran Rådegran, Lars Gullestad, Göran Dellgren, Kjell Jansson
Publikováno v:
Relbo Authen, A, Grov, I, Karason, K, Gustafsson, F, Eiskjaer, H, Rådegran, G, Gude, E, Jansson, K, Dellgren, G, Solbu, D, Arora, S, Andreassen, A K & Gullestad, L 2017, ' Effect of everolimus vs calcineurin inhibitors on quality of life in heart transplant recipients during a 3-year follow-up : Results of a randomized controlled trial (SCHEDULE) ', Clinical Transplantation, vol. 31, no. 9 . https://doi.org/10.1111/ctr.13038
The Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial was a 12 month, randomized, open-label, parallel-group trial that compared everolimus (EVR; n=56) to conventional CsA (n=59) immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9453ee64337354be12104c099800b8ef
https://pure.au.dk/portal/da/publications/effect-of-everolimus-vs-calcineurin-inhibitors-on-quality-of-life-in-heart-transplant-recipients-during-a-3year-followup(8893b8aa-f769-4454-9c65-2a5c4cfe8944).html
https://pure.au.dk/portal/da/publications/effect-of-everolimus-vs-calcineurin-inhibitors-on-quality-of-life-in-heart-transplant-recipients-during-a-3year-followup(8893b8aa-f769-4454-9c65-2a5c4cfe8944).html
Publikováno v:
Abstracts Accepted for Publication.
Objectives SUSTAIN is a prospective, multi-center non-interventional study in Germany to observe long term efficacy and safety, quality of life and further patient reported outcomes in patients with active psoriatic arthritis under treatment with Ust
Autor:
Fauze Maluf-Filho, João Nunes de Matos Neto, Nils Gunnar Skare, Hezio Jadir Fernandes Júnior, Maria Nunes Álvares, J.G.M. Segalla, Bruno de Araújo Lima França, Ismael Dale Cotrim Guerreiro da Silva, Carlos J C Andrade, Auro Del Giglio, Giuliano Santos Borges, Gustavo Girotto, Nora Manoukian Forones, Sergio J Azevedo, Nicolas Lazaretti, Daniel Grabarz, Gilberto de Castro Junior, Celio Kussumoto, José Luiz Pedrini
Publikováno v:
European journal of cancer (Oxford, England : 1990). 88
Purpose Chemoradiotherapy is the standard treatment for patients with inoperable locally advanced oesophageal cancer. We sought to assess the safety and efficacy of chemoradiation combined with nimotuzumab, a humanised antibody directed against epide